Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Assets Average (2021 - 2026)

Bioventus filings provide 5 years of Assets Average readings, the most recent being $692.6 million for Q4 2025.

  • On a quarterly basis, Assets Average fell 7.5% to $692.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $692.6 million, a 7.5% decrease, with the full-year FY2025 number at $705.8 million, down 8.28% from a year prior.
  • Assets Average hit $692.6 million in Q4 2025 for Bioventus, down from $704.2 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $1.4 billion in Q4 2022 to a low of $568.8 million in Q2 2021.
  • Median Assets Average over the past 5 years was $797.9 million (2024), compared with a mean of $873.3 million.
  • Biggest five-year swings in Assets Average: skyrocketed 113.0% in 2022 and later plummeted 41.46% in 2023.
  • Bioventus' Assets Average stood at $940.3 million in 2021, then skyrocketed by 47.33% to $1.4 billion in 2022, then plummeted by 41.46% to $811.0 million in 2023, then decreased by 7.68% to $748.7 million in 2024, then fell by 7.5% to $692.6 million in 2025.
  • The last three reported values for Assets Average were $692.6 million (Q4 2025), $704.2 million (Q3 2025), and $699.1 million (Q2 2025) per Business Quant data.